Dr. Henry Pelish is the Chief Scientific Officer of Nuvalent. He contributed the creation of Nuvalent and joined the company as its first employee 6 years ago. Henry earned his PhD in Chemistry from Harvard University (field of Organic Chemistry and Chemical Biology) and held a postdoctoral appoint in the Cell Biology Department at Harvard Medical School.
Can help with
Life sciences company creation, building, and management; drug discovery and development strategies
